Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Kiniksa Pharmaceuticals Ltd
Net Income (Common)
Kiniksa Pharmaceuticals Ltd
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
|
Net Income (Common)
$8.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Kiniksa Pharmaceuticals Ltd's Net Income (Common)?
Net Income (Common)
8.6m
USD
Based on the financial report for Mar 31, 2024, Kiniksa Pharmaceuticals Ltd's Net Income (Common) amounts to 8.6m USD.
What is Kiniksa Pharmaceuticals Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 1Y
-96%
Over the last year, the Net Income (Common) growth was -96%.